ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Rheumatology Network

RA Guidelines Emphasize Costs and Shared Decision Making

12 treatment recommendations for rheumatoid arthritis you should know about. (©ValentinT/Shutterstock.com)

 

Recent Content

(Synovial joint anatomy abstract. ©Tefi/Shutterstock.com)

The orally administered once-daily peficitinib without concomitant use of methotrexate reduces symptoms of rheumatoid arthritis in trial.

©SebastianKaulitzki/Shuttersstock.com

Innate lymphoid cells have a clear role in rheumatic disease and its related inflammatory process.

(©EdwardOlive/Shutterstock.com)

EULAR has updated its guidelines for treating rheumatoid arthritis. In this slideshow, we highlight the recommendations.

(©PavelLPhotoVideo/Shutterstock.com)

Tocilizumab in its subcutaneous form is the first-ever drug designated for giant cell arteritis which affects 230,000 people in the U.S

Kevzara (Sarilumab). Photo courtesy of ©Sanofi, Regeneron.

The IL-6 inhibitor offers a monotherapy option for hard-to-treat rheumatoid arthritis cases.

(©Masycheva/Shutterstock.com)

Systemic sclerosis. Its rarity could lead to delays in diagnosis which, according to a review, may not be fully understood by inexperienced physicians.

(©Toa55/Shutterstock.com)

Study of long-term outcomes in rheumatoid arthritis supports early window of opportunity treatment theory.

By clicking Accept, you agree to become a member of the UBM Medica Community.